DE68922540D1 - Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene. - Google Patents

Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene.

Info

Publication number
DE68922540D1
DE68922540D1 DE68922540T DE68922540T DE68922540D1 DE 68922540 D1 DE68922540 D1 DE 68922540D1 DE 68922540 T DE68922540 T DE 68922540T DE 68922540 T DE68922540 T DE 68922540T DE 68922540 D1 DE68922540 D1 DE 68922540D1
Authority
DE
Germany
Prior art keywords
retrovirus
hiv
envelope glycoprotein
protein
precursors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68922540T
Other languages
English (en)
Other versions
DE68922540T2 (de
Inventor
Luc Montagnier
Ara Hovanessian
Anne Laurent
Bernard Krust
Marie-Anne Rey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8807817A external-priority patent/FR2632644B1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of DE68922540D1 publication Critical patent/DE68922540D1/de
Publication of DE68922540T2 publication Critical patent/DE68922540T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
DE68922540T 1988-06-09 1989-06-09 Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene. Expired - Lifetime DE68922540T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20434688A 1988-06-09 1988-06-09
FR8807817A FR2632644B1 (fr) 1988-06-10 1988-06-10 Antigenes precurseurs des glycoproteines d'enveloppe d'un retrovirus humain hiv-2 et antigenes presentant une parente immunologique avec ces derniers. preparation de ces antigenes. application au diagnostic

Publications (2)

Publication Number Publication Date
DE68922540D1 true DE68922540D1 (de) 1995-06-14
DE68922540T2 DE68922540T2 (de) 1995-10-05

Family

ID=26226719

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68922540T Expired - Lifetime DE68922540T2 (de) 1988-06-09 1989-06-09 Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene.

Country Status (9)

Country Link
EP (1) EP0354072B1 (de)
JP (1) JP3093763B2 (de)
AT (1) ATE122236T1 (de)
CA (1) CA1341488C (de)
DE (1) DE68922540T2 (de)
DK (1) DK175668B1 (de)
ES (1) ES2074085T3 (de)
HK (1) HK167295A (de)
PT (1) PT90800B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005078443A1 (en) * 2004-02-13 2005-08-25 Inverness Medical Switzerland Gmbh Determination of infection by the immune response to a carbohydrate moiety

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249611A4 (de) * 1985-11-14 1988-04-26 Harvard College T-lymphotrophisches virus.
EP0269520A3 (de) * 1986-11-21 1988-08-24 Institut Pasteur Zum Hervorrufen von AIDS geeignetes Retrovirus vom HIV-2-Typ sowie seine Antigen- und Nukleinsäurebestandteile
ES2104556T3 (es) * 1987-01-16 1997-10-16 Pasteur Institut Peptidos que tienen propiedades inmunologicas de hiv-2.

Also Published As

Publication number Publication date
HK167295A (en) 1995-11-03
ATE122236T1 (de) 1995-05-15
DK284389D0 (da) 1989-06-09
DE68922540T2 (de) 1995-10-05
PT90800B (pt) 1994-11-30
EP0354072A1 (de) 1990-02-07
PT90800A (pt) 1989-12-29
CA1341488C (fr) 2005-08-30
ES2074085T3 (es) 1995-09-01
EP0354072B1 (de) 1995-05-10
DK284389A (da) 1989-12-10
JPH02119791A (ja) 1990-05-07
DK175668B1 (da) 2005-01-10
JP3093763B2 (ja) 2000-10-03

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
MY136081A (en) Modified hiv - 1gag p17 peptide and immunogenic composition
ATE64601T1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
DK513388A (da) Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2
CY1107570T1 (el) Ανοσογονικα πολυπεπτιδια κωδικοποιουμενα απο μινιγονιδια mage και οι χρησεις τους
DE60039036D1 (de) Hiv-peptide, antigene und impfstoffzusammensetzungen
EP0429477A4 (en) Synthetic vaccine against aids virus
JP2001527029A5 (de)
FI885296A0 (fi) Rekombinant hiv-2 polypeptid.
DE68922540T2 (de) Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene.
NZ220500A (en) Recombinant felv polypeptide; vaccine and expression vectors
ATE247485T1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
ATE136789T1 (de) Antigene eines transmembranen hüllenglycoproteins eines menschlichen retrovirus des typs hiv-2 und immunologisch verwandte antigene
OA08716A (fr) Peptides susceptibles d'être reconnus par des anticorps induits contre des retrovirus d'immunodéficience humaine (virus HIV), leurs applications au diagnostic des infections dues à certains de ces virus et, le cas échéant, à la vaccination contre le sida.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition